OPKO Health, Inc. (TLV: OPK)
Israel
· Delayed Price · Currency is ILS · Price in ILA629.90
+7.20 (1.16%)
Nov 18, 2024, 5:24 PM IDT
OPKO Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 711.41 | 863.5 | 1,004 | 1,775 | 1,435 | 901.94 | Upgrade
|
| Revenue Growth (YoY) | -17.94% | -14.01% | -43.42% | 23.64% | 59.15% | -8.92% | Upgrade
|
| Cost of Revenue | 627.03 | 634.96 | 789.86 | 1,270 | 969.72 | 690.35 | Upgrade
|
| Gross Profit | 84.38 | 228.53 | 214.33 | 504.67 | 465.69 | 211.58 | Upgrade
|
| Selling, General & Admin | 310.07 | 300.56 | 372.67 | 468.86 | 355.57 | 330.71 | Upgrade
|
| Operating Expenses | 393.85 | 386.59 | 460.46 | 519.14 | 411.96 | 395.49 | Upgrade
|
| Operating Income | -309.48 | -158.06 | -246.12 | -14.46 | 53.73 | -183.91 | Upgrade
|
| Interest Expense | -36.68 | -13.51 | -12.06 | -18.88 | -21.93 | -21.52 | Upgrade
|
| Interest & Investment Income | 5.04 | 3.98 | 1.98 | 0.03 | 0.15 | 1.71 | Upgrade
|
| Earnings From Equity Investments | -0.02 | -0.11 | -0.38 | -0.63 | -0.48 | -2.9 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.2 | 1.2 | -1.8 | -1.4 | 1.6 | 0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -50.32 | -18.42 | -149.83 | 3.46 | 11.15 | -3.46 | Upgrade
|
| EBT Excluding Unusual Items | -388.26 | -184.91 | -408.21 | -31.88 | 44.21 | -209.68 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -26.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | 148.9 | -0.56 | -3.57 | -4.87 | 0.01 | -8.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | 121.49 | - | 18.56 | 31.51 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -66.2 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -12.6 | Upgrade
|
| Other Unusual Items | 0.01 | 1.04 | 1.31 | -9.41 | 3.99 | 14.85 | Upgrade
|
| Pretax Income | -117.86 | -184.43 | -391.9 | -14.65 | 48.2 | -307.87 | Upgrade
|
| Income Tax Expense | 15.88 | 4.44 | -63.5 | 15.49 | 17.62 | 7.06 | Upgrade
|
| Earnings From Continuing Operations | -133.73 | -188.86 | -328.41 | -30.14 | 30.59 | -314.93 | Upgrade
|
| Net Income | -133.73 | -188.86 | -328.41 | -30.14 | 30.59 | -314.93 | Upgrade
|
| Net Income to Common | -133.73 | -188.86 | -328.41 | -30.14 | 30.59 | -314.93 | Upgrade
|
| Shares Outstanding (Basic) | 713 | 752 | 719 | 648 | 641 | 595 | Upgrade
|
| Shares Outstanding (Diluted) | 713 | 752 | 719 | 648 | 641 | 595 | Upgrade
|
| Shares Change (YoY) | -5.19% | 4.55% | 10.95% | 1.16% | 7.59% | 5.74% | Upgrade
|
| EPS (Basic) | -0.19 | -0.25 | -0.46 | -0.05 | 0.05 | -0.53 | Upgrade
|
| EPS (Diluted) | -0.19 | -0.25 | -0.46 | -0.05 | 0.05 | -0.53 | Upgrade
|
| Free Cash Flow | -199.99 | -44.47 | -119.77 | 6.18 | 5.79 | -185.26 | Upgrade
|
| Free Cash Flow Per Share | -0.28 | -0.06 | -0.17 | 0.01 | 0.01 | -0.31 | Upgrade
|
| Gross Margin | 11.86% | 26.47% | 21.34% | 28.44% | 32.44% | 23.46% | Upgrade
|
| Operating Margin | -43.50% | -18.30% | -24.51% | -0.81% | 3.74% | -20.39% | Upgrade
|
| Profit Margin | -18.80% | -21.87% | -32.70% | -1.70% | 2.13% | -34.92% | Upgrade
|
| Free Cash Flow Margin | -28.11% | -5.15% | -11.93% | 0.35% | 0.40% | -20.54% | Upgrade
|
| EBITDA | -209.36 | -52.76 | -137.47 | 64.26 | 139.09 | -90.1 | Upgrade
|
| EBITDA Margin | -29.43% | -6.11% | -13.69% | 3.62% | 9.69% | -9.99% | Upgrade
|
| D&A For EBITDA | 100.12 | 105.3 | 108.66 | 78.72 | 85.36 | 93.81 | Upgrade
|
| EBIT | -309.48 | -158.06 | -246.12 | -14.46 | 53.73 | -183.91 | Upgrade
|
| EBIT Margin | -43.50% | -18.30% | -24.51% | -0.81% | 3.74% | -20.39% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 36.55% | - | Upgrade
|
| Revenue as Reported | 711.41 | 863.5 | 1,004 | 1,775 | 1,435 | 901.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.